YahooSeptember 4, 2026 at 5:21 AM NYLast Month
Did Recalls And Cyberattack Disruptions Just Shift Boston Scientific's (BSX) Investment Narrative?
In recent weeks, Boston Scientific has faced multiple voluntary global recalls of its Suture Cinch endoscopic devices and ENROUTE Transcarotid Neuroprotection systems, alongside a cybersecurity incident that disrupted operations and led to reduced full‑year 2026 sales and earnings guidance. These simultaneous product quality issues, operational disruptions, and softer demand for key franchises raise fresh questions about the resilience of Boston Scientific’s previously growth-focused...
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
